SEC Form 4 · accession 0001171843-18-005699
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley J Hartman
Officer — VP, People
Period of report
Aug 1, 2018
Accepted (ET)
Aug 2, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.125 | Aug 1, 2018 | A | 150,000 | A | — | Jul 31, 2028 | Common Stock, $0.001 par value | 150,000 | 150,000 | D |
Explanation of responses
- F1The options were granted on August 1, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.